Donor-derived cell-free DNA testing for noninvasive monitoring of allograft rejection after lung transplantation
BackgroundDonor-derived cell-free DNA (dd-cfDNA) is a promising noninvasive marker of graft injury after lung transplantation (LTx), but its real-world value for identifying rejection-associated allograft injury and its interpretation across infection …